Is mirabegron equally as effective when used as first- or second-line therapy in women with overactive bladder?
Crossref DOI link: https://doi.org/10.1007/s00192-016-3219-x
Published Online: 2016-12-10
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Serati, Maurizio
,
Leone Roberti Maggiore, Umberto
Sorice, Paola
Cantaluppi, Simona
Finazzi Agrò, Enrico
Ghezzi, Fabio
License valid from 2016-12-10